Other research

Other research

The Leuven Diabetes Lab has access to cutting-edge flow cytometry and single-cell technologies through grant-funded infrastructure, with support from Dr. Chantal Mathieu’s strategic leadership.

6/5/2025
-
4/6/2030
A real-time (quantitative) PCR and digital PCR system

Promotors:

Chantal Mathieu

1/1/2023
-
12/31/2024
Unique IsoPlexis technology for multiplexed single cell functional profiling

Promotors:

Chantal Mathieu

5/1/2022
-
4/30/2026
Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometry

Promotors:

Chantal Mathieu

5/1/2020
-
4/30/2024
Translational research-oriented technology platform for single cell analysis

Promotors:

Chantal Mathieu

5/1/2018
-
4/30/2022
Mass cytometry by time-of-flight: next-generation flow cytometry for multiplexed single cell analysis.

Promotors:

Chantal Mathieu

10/1/2016
-
9/30/2018
Histology: a vital tool for endocrine and metabolic research

Promotors:

Chantal Mathieu

7/1/2016
-
12/31/2025
Continued provision of an affordable medium-parametric cell analysis solution at the KU Leuven FACS Core

Promotors:

Chantal Mathieu

6/26/2014
-
12/25/2018
Automated platform for high-throughput microbiome analysis

Promotors:

Chantal Mathieu

7/22/2010
-
1/21/2017
FACSAria II, central to the establishment of the KU Leuven FACS Core

Promotors:

Chantal Mathieu

10/20/2008
-
4/19/2015
Beckman Coulter Gallios flow cytometer

Promotors:

Chantal Mathieu

Support us

Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund. 

By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and curing type 1 diabetes.
Every contribution moves us one step closer to breakthroughs that matter.